Our Clinically-driven pharmacy care model reduces specialty drug costs by finding the best combination of medications to help improve patient health, while reducing side effects and unnecessary expense. Our clinical pharmacists achieve these positive results by analyzing patients’ health and recommending a range of clinically-appropriate medication therapies. These include non-specialty medications that are comparable but lower cost and biosimilars.

• • 90% generic dispensing rate – Does your PBM prefer brands over generics?
  • 64% therapeutic switch rate – If your PBM is just rubber-stamping claims and not actively managing your pharmacy benefits program, you should consider a new pharmacy care partner.

HRMorning Article

​​​​HRMorning recently published a major article highlighting the growing momentum behind PBM reform, starting with Arkansas’ newly adopted law that prohibits PBMs from owning pharmacies. This law has already triggered legal challenges from CVS Caremark and Express Scripts. It has also sparked a much-needed conversation around state-level PBM reform efforts, especially as federal reform action continues to stall.

The article spotlights EmpiRx Health and our recently launched AllyRx national pharmacy care network as examples of “emerging care models” that HR and total benefits executives should be considering in today’s evolving PBM landscape. The piece also provides a detailed look at EmpiRx Health’s partnership with Giant Eagle, showcasing how the pharmacist-led AllyRx pharmacy network is delivering on the promise of lower costs, better health outcomes, and true transparency for plan sponsors and patients alike.

As the market shifts toward accountability and patient-centric care, EmpiRx Health is proud to be setting a new pharmacy care standard. This is PBM reform in action. Read more by clicking the button below.